Last updated: September 10, 2019
Sponsor: Hadassah Medical Organization
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hormone Deficiencies
Diabetes (Pediatric)
Treatment
N/AClinical Study ID
NCT02380339
0098-14-HMO-CTIL
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Type 1 diabetic patient, male and females above the age of 18.
Patients with significant fear of hypoglycemia as indicated in the HFS-W (equals orgreater than 3 on at least one of the item on the HFS-W ).
Exclusion
Exclusion Criteria: Patient with severe hypoglycemia event in the last 6 months will be excluded. Patient withmental illness will be excluded
Study Design
Total Participants: 20
Study Start date:
March 01, 2018
Estimated Completion Date:
December 31, 2019
Connect with a study center
Hadassah Medical Organization, Jerusalem, Israel
Jerusalem,
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.